Immuneonco Biopharmaceutical Inc. (1541)
Market Closed
17 Jul, 08:00
HKEX 
XFRA Primary HKEX 3. 46
HKD -0.18
-4.9451%
2.28B Market Cap
- P/E Ratio
- Div Yield
1M Volume
- Eps
3.64 HKD
Previous Close Want to track 1541 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuneonco Biopharmaceutical Inc. (1541) Statistics
Valuation metrics
Market Cap 2.28B
Enterprise value 803.95M
Trailing P/E (ttm) -5.63
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) 7.93
Price/Book (mrq) 1.6
Enterprise Value/Revenue 5.08
Enterprise Value/EBITDA -3.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 548.92K
Average volume (90 days) 1.45M
Price summary
52-Week low 2.8
52-Week high 16.8
Beta -
50-Day moving average 3.51
200-Day moving average 4.47
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.37%
Operating margin -1.36%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.33%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.51
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 3.83%
Book value per share (mrq) 1.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
